Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

roadsysiot.com Blueprint · Rev.39

Sheet A · Product board

aod9604 lozenges AOD-9604 10mg Size:20mg Pre-Filled Pen (SubQ) AHK-CU Bundle

Unit price

USD25.43

USD53.43

Pay in 4 interest-free payments of $6.36 Learn more

Field rating

4.1

Verified studio score · Spec revision current

Fit · Size

aod9604 lozenges

aod9604 lozenges AOD-9604 10mg Size:20mg Pre-Filled Pen (SubQ) AHK-CU Bundle

SKU: 73614792118

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 5 - Sep 10

Description

aod9604 lozenges AOD-9604 10mg Size:20mg Pre-Filled Pen (SubQ) AHK-CU Bundle

AHK-CU

Reconstituted tesamorelin is highly fragile

Bundle

Size:20mg Pre-Filled Pen (SubQ)

Tirzepatide requires one injection per week at any time

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here's what happens next

Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here's what happens next

US$ 25.25

4.7 (8 reviews)

Is BPC-157 Legal in 2026? FDA Compounding Status Explained

Is BPC-157 Legal in 2026? FDA Compounding Status Explained

US$ 25.85

4.8 (15 reviews)

Did the FDA Just Approve BPC-157?

Did the FDA Just Approve BPC-157?

US$ 29.84

4.2 (21 reviews)

FDA panel votes to place popular peptide BPC-157 on compounding list

FDA panel votes to place popular peptide BPC-157 on compounding list

US$ 24.26

4.5 (8 reviews)

BPC-157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective – MSK Doctor Zaid Matti

BPC-157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective – MSK Doctor Zaid Matti

US$ 24.21

4.5 (21 reviews)

BPC-157 Legal Status: FDA Regulations and Compounding

BPC-157 Legal Status: FDA Regulations and Compounding

US$ 21.17

4.1 (15 reviews)

BPC-157 in 2026: Why Regulatory Limbo Is Not the Same as a Green Light – Holt Law

BPC-157 in 2026: Why Regulatory Limbo Is Not the Same as a Green Light – Holt Law

US$ 26.25

4.3 (18 reviews)

FDA July 2026 Peptide Meeting: Approval, Access & Safety

FDA July 2026 Peptide Meeting: Approval, Access & Safety

US$ 25.44

4.8 (14 reviews)

BPC-157 FDA Approval Status 2026: Clinical Trials

BPC-157 FDA Approval Status 2026: Clinical Trials

US$ 20.08

4.5 (22 reviews)

BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

US$ 26.12

4.1 (18 reviews)

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

US$ 22.78

4.8 (25 reviews)

FDA Discusses Peptide Bulk Substances BPC-157 and More | Hillary Lin, MD posted on the topic

FDA Discusses Peptide Bulk Substances BPC-157 and More | Hillary Lin, MD posted on the topic

US$ 24.13

4.7 (23 reviews)

Survey: Half of Peptide-Users Aren't Aware of FDA Approval Status

Survey: Half of Peptide-Users Aren't Aware of FDA Approval Status

US$ 22.44

4.3 (28 reviews)

Big FDA review coming this July. Here's what athletes and patients should know about BPC-157, TB-500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #

Big FDA review coming this July. Here's what athletes and patients should know about BPC-157, TB-500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #

US$ 26.07

4.8 (6 reviews)

BPC 157 Banned: Key Facts on the Latest FDA Decision

BPC 157 Banned: Key Facts on the Latest FDA Decision

US$ 29.15

4.7 (16 reviews)

FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR

FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR

US$ 25.15

4.3 (10 reviews)

FDA moves BPC-157 to Category 1 by…? Predictions & Odds 2026

FDA moves BPC-157 to Category 1 by…? Predictions & Odds 2026

US$ 29.44

4.0 (10 reviews)

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. FULL STORY: bit.ly/4vVCuH4

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. FULL STORY: bit.ly/4vVCuH4

US$ 25.78

4.4 (8 reviews)

The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies ⁠to produce more than a dozen injectable peptides that were banned because of ⁠potentially significant safety risks, the New York

The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies ⁠to produce more than a dozen injectable peptides that were banned because of ⁠potentially significant safety risks, the New York

US$ 26.45

4.7 (8 reviews)

In July 2026, an FDA advisory committee voted to add six of seven peptides to a drug compounding list. Although the vote does not mean FDA approval, the recommendation brings these popular

In July 2026, an FDA advisory committee voted to add six of seven peptides to a drug compounding list. Although the vote does not mean FDA approval, the recommendation brings these popular

US$ 22.40

4.9 (14 reviews)